Alyeska Investment Group, L.P. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 42 filers reported holding XENON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,211,000
+72.0%
247,057
-0.9%
0.01%
+66.7%
Q4 2017$704,000
-46.9%
249,284
-44.5%
0.01%
-40.0%
Q3 2017$1,325,000
-4.7%
449,284
+1.8%
0.01%
-16.7%
Q2 2017$1,390,000
-21.0%
441,260
+0.3%
0.01%
-14.3%
Q1 2017$1,760,000439,8940.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders